This commentary refers to `Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial', by C. Chimenti et al., https:// doi.org/10.1093/eurheartj/ehac348 and the discussion piece `Individualized immunosuppression in virus-negative inflammatory cardiomyopathy', by A. Frustaci et al., https:// doi.org/10.1093/eurheartj/ehac559.
Immunosuppressive therapy of myocarditis and inflammatory cardiomyopathy in the light of new data
Caforio A. L. P.
2022
Abstract
This commentary refers to `Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial', by C. Chimenti et al., https:// doi.org/10.1093/eurheartj/ehac348 and the discussion piece `Individualized immunosuppression in virus-negative inflammatory cardiomyopathy', by A. Frustaci et al., https:// doi.org/10.1093/eurheartj/ehac559.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
